Status:
UNKNOWN
Symptom Clusters in Hong Kong Chinese Children With Blood Cancer
Lead Sponsor:
The Hong Kong Polytechnic University
Conditions:
Child
Eligibility:
All Genders
5-17 years
Brief Summary
Pediatric blood cancer is the most common childhood malignancy. Despite its survival has been substantially improved, children still have to pay a high price for numerous distressing symptoms resulted...
Detailed Description
A longitudinal study design will be conducted. A sample of 120 patients age 5-17years, diagnosed with blood cancer but not yet receive any chemotherapy and able to communicate with Cantonese and read ...
Eligibility Criteria
Inclusion
- aged 5 - 17 years old
- diagnosed with blood cancer but not yet receive any chemotherapy
- able to communicate with Cantonese and read Chinese
Exclusion
- who are scheduled to have concurrent cancer treatment
- with recurrent malignancy
- medical condition, or cognitive and learning problems in their medical records
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04888195
Start Date
September 1 2021
End Date
September 1 2024
Last Update
April 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ka Yan Ho
Hong Kong, Hong Kong,China, Hong Kong, 0000